Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B London

Showing results (121-130 of 310) with videos related to

Pageof 31
Sort By:
JAMA Network Open|July 8, 2021
Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk NeuroblastomaSkye Balyasny, Sang Mee Lee, Ami V Desai, et al.
Journal of the American Academy of Dermatology|March 29, 2018
Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in childrenJennifer T Huang, Johanna S Song, Elena B Hawryluk, et al.
Bone Marrow Transplantation|April 4, 2017
Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantationJ S Song, W B London, E B Hawryluk, et al.
Circulation|March 29, 2001
Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failureD M McNamara, R Holubkov, K Janosko, et al.
Pediatric Blood & Cancer|May 23, 2019
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) projectKevin Campbell, Derek Shyr, Rochelle Bagatell, et al.
American Journal of Hematology|January 13, 2015
Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictorsCraig M Forester, Sarah E Sartain, Dongjing Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage diseaseM Omura-Minamisawa, M B Diccianni, R C Chang, et al.
BMJ Open|August 28, 2021
Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocolKristin A Shimano, Rachael F Grace, Jenny M Despotovic, et al.
Cancer Research|September 1, 2010
microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastomaRuey-Jen Lin, You-Chin Lin, Jeremy Chen, et al.
Circulation Research|November 14, 1997
Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ currentB London, M C Trudeau, K P Newton, et al.
Pageof 31

Showing results (121-130 of 310) with videos related to

Sort By:
Pageof 31
JAMA Network Open|July 8, 2021
Association Between Participation in Clinical Trials and Overall Survival Among Children With Intermediate- or High-risk NeuroblastomaSkye Balyasny, Sang Mee Lee, Ami V Desai, et al.
Journal of the American Academy of Dermatology|March 29, 2018
Nonmalignant late cutaneous changes after allogeneic hematopoietic stem cell transplant in childrenJennifer T Huang, Johanna S Song, Elena B Hawryluk, et al.
Bone Marrow Transplantation|April 4, 2017
Risk of melanocytic nevi and nonmelanoma skin cancer in children after allogeneic hematopoietic stem cell transplantationJ S Song, W B London, E B Hawryluk, et al.
Circulation|March 29, 2001
Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failureD M McNamara, R Holubkov, K Janosko, et al.
Pediatric Blood & Cancer|May 23, 2019
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) projectKevin Campbell, Derek Shyr, Rochelle Bagatell, et al.
American Journal of Hematology|January 13, 2015
Pediatric aplastic anemia and refractory cytopenia: A retrospective analysis assessing outcomes and histomorphologic predictorsCraig M Forester, Sarah E Sartain, Dongjing Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2001
p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage diseaseM Omura-Minamisawa, M B Diccianni, R C Chang, et al.
BMJ Open|August 28, 2021
Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocolKristin A Shimano, Rachael F Grace, Jenny M Despotovic, et al.
Cancer Research|September 1, 2010
microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastomaRuey-Jen Lin, You-Chin Lin, Jeremy Chen, et al.
Circulation Research|November 14, 1997
Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ currentB London, M C Trudeau, K P Newton, et al.
Pageof 31